SGLT2 inhibitors use not tied to significant risk of amputations in diabetics: Study

Singapore: A meta-analysis of 15 randomized controlled trials of SGLT2 inhibitors for diabetes and non-diabetes patients, showed no significant difference in amputation risk for the various SGLT2...

Related Keywords

Singapore ,National University Of Singapore ,Singapore General , ,Canagliflozin Cardiovascular Assessment Study ,National University ,Sodium Glucose Cotransporter ,Amputation Events ,Systematic Review ,Randomized Controlled Trials ,Sglt2 Inhibitors ,Amputation ,Diabetes Complications ,Seer M ,Diabetes ,Sodium Glucose Cotransporter 2 Inhibitors ,